MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $221 | -21.4% | 27,369 | +6.1% | 0.00% | – |
| Q2 2023 | $281 | +106.6% | 25,798 | +31.0% | 0.00% | – |
| Q1 2023 | $136 | +47.8% | 19,700 | -14.7% | 0.00% | – |
| Q4 2022 | $92 | -99.9% | 23,100 | +48.1% | 0.00% | – |
| Q3 2022 | $104,000 | +36.8% | 15,600 | 0.0% | 0.00% | – |
| Q2 2022 | $76,000 | -27.6% | 15,600 | +39.5% | 0.00% | – |
| Q1 2022 | $105,000 | -83.9% | 11,183 | -73.5% | 0.00% | – |
| Q1 2021 | $653,000 | – | 42,186 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 3,629,622 | $41,305,000 | 7.74% |
| VR Adviser, LLC | 2,641,809 | $30,064,000 | 3.86% |
| Bleichroeder LP | 1,062,500 | $12,091,000 | 1.96% |
| Bain Capital Life Sciences Investors, LLC | 1,431,058 | $16,285,000 | 1.01% |
| Boxer Capital, LLC | 2,400,000 | $27,312,000 | 0.95% |
| 683 Capital Management, LLC | 1,929,929 | $21,963,000 | 0.86% |
| Avoro Capital Advisors LLC | 3,235,000 | $36,814,000 | 0.58% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,197,426 | $25,007,000 | 0.42% |
| Granite Point Capital Management, L.P. | 419,324 | $4,772,000 | 0.36% |
| KNOTT DAVID M | 81,166 | $924,000 | 0.34% |